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Summary
Objective: To non-invasively investigate the changes to epiphyseal bone occurring in a longitudinal pre-clinical model of osteoarthritis (OA)
using in vivo micro-computed tomography (micro-CT).
Design: In vivo micro-CT images were acquired using a bench-top micro-CT scanner, which produces three-dimensional data with isotropic
voxel spacing of 0.046 mm. Male rodents were scanned prior to surgical destabilization, consisting of anterior cruciate ligament transection
and partial medial menisectomy (ACLX). Subsequent scans were performed every 4 weeks post-ACLX, for up to 5 months. Volumetric
bone mineral density (vBMD) was measured in speciﬁc, anatomically segmented regions within each image. The ACLX rodent data were com-
pared with the contralateral non-operated hind limb of the same animal, as well as a sham-operated group (SHAM) of animals, for each time
point. End-point histology compared changes to cartilage and bone between the ACLX and control animals.
Results: The micro-CT protocol produced sufﬁcient spatial resolution and signal-to-noise ratio (SNR¼ 19) to quantify subchondral bone pa-
thology, with an acceptable entrance exposure to radiation (0.36 Gy). Signiﬁcantly lower vBMD was measured in the ACLX group, vs SHAM
rodents, at 1, 4, and 5 months post-surgery (P< 0.05). Qualitative observations of ACLX joints revealed signiﬁcant loss of cartilage, subchon-
dral bone cysts, and calciﬁcation of tendon similar to changes found in humans.
Conclusions: This study demonstrates in vivo micro-CT as an effective method for investigating the development of rodent knee OA longitu-
dinally. This method can be applied, in future pre-clinical trials, to non-destructively monitor the efﬁcacy of pharmacological interventions.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a degenerative disease, having a com-
plex etiopathology1e3, affecting both the articular cartilage
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458OA is the most prevalent form of arthritis6, and contributes
signiﬁcant economical and social impacts to the patient,
the health care system, and the labour force in Canada7.
With the advent of an aging population, OA is projected to
affect an increasing number of Canadians8, which is driving
the demand for disease-modifying OA drugs (DMOADs) to
treat the functional deﬁcits, along with the symptoms. It is
therefore of critical importance to adopt a pre-clinical model
of OA that is reproducible and can be used to investigate
the mechanisms of this disease, with the hopes of studying
pharmacological interventions longitudinally.
Before clinical trials of a new drug can begin, investiga-
tions are carried out in animal models that produce
human-like OA characteristics9e11. Most animal-model
studies use large species, such as cows11, sheep12, or
dogs13 in order to obtain sufﬁcient amounts of tissue for his-
tological or histomorphometric analyses. However, the
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mals may limit the number of samples used for longitudinal
investigations of joint degeneration. To offset animal-care
costs, many investigators have chosen smaller species, in-
cluding rabbits14,15, guinea pigs16, and rodents17 to exam-
ine the initiation and progression of OA. Rodents are of
particular interest (with well-established genomes) in the
areas of research determining the genetic links or changes
in expression that occur in OA18,19. The rat speciﬁcally is an
ideal animal model for longitudinal, in vivo research due to
their ease of handling and housing, and their ability to sup-
port surgical20 and adjuvant induced21 OA.
Improvements in non-destructive imaging modalities
such as magnetic resonance imaging (MRI) and computed
tomography (CT) allow investigators to create images of
the three-dimensional (3D) architecture of joints in humans
with OA22. However, two-dimensional (2D) radiographs are
still the clinical standard for humans23, though recent
studies suggest difﬁculties in consistently grading radio-
graphs, and correlating the grade to pain and joint func-
tion23,24. MRI has been identiﬁed as the preferred tool for
future clinical trials25 but it is limited to using larger animals
in pre-clinical trials due to insufﬁcient spatial resolution. In-
creasing the ﬁeld strength can offset this disadvantage and
improve the signal-to-noise ratio (SNR)26, but the length of
scan time needed to acquire these images with sufﬁcient
spatial resolution makes in vivo data acquisition exceed-
ingly difﬁcult. Most investigators have used ex vivo MRI
analyses with dogs27, rabbits15, or guinea pigs28 to obtain
excellent cartilage and bone images, while those perform-
ing in vivo experiments use rabbits and guinea pigs with
some form of contrast agent to enhance visualization
of soft tissue29. Recently, micro-computed tomography
(micro-CT) systems have become available that can pro-
vide superior spatial resolution and contrast between
bone and soft tissue, when compared to clinical CT.
Most systems implement micro-focus X-ray tubes com-
bined with megapixel charge-coupled device (CCD) detec-
tors to create very high-resolution images with varying
isotropic voxel sizes from 10 to 100 microns (mm)30,31.
The use of these systems is quickly becoming a standard
reference tool for the pre-clinical and non-destructive anal-
ysis of bone density, stereology or architecture in small an-
imals31,32 and bone specimens33,34.
Our previous experience using non-invasive micro-CT
and high-ﬁeld MRI imaging with a rabbit model of OA accu-
rately portrayed progressive changes to cartilage, the volu-
metric bone mineral density (vBMD), and the development
of osteophytes in the knee14,15. However, this analysis
was performed ex vivo, requiring animal euthanasia at
each desired interval. Concurrent advances in non-invasive
micro-CT imaging can now allow in vivo imaging of small-
animal joints with isotropic resolution between 25 and
100 mm35,36 in as little as 10 min. Thus, the purpose of
this study was to incorporate this new technology with
a more cost-effective, longitudinal animal model of OA.
We have accomplished this purpose by using a surgical de-
stabilization model in the rodent knee. It is our belief that
in vivo micro-CT imaging, when applied to a rodent anterior
cruciate ligament transection with partial menisectomy
(ACLX) model, accurately characterizes the changes to
subchondral bone in human-like OA development. In this
longitudinal study over a 5-month period, we were able to
accurately quantify the changes to vBMD and joint derange-
ment in the same animal during the initiation, progression,
and end stages (or joint failure) of OA development. This
validation study sets the precedent for future investigationsinto possible treatments or pharmacological interventions
using our non-invasive and longitudinal model.Materials and methodsANIMAL MODELAll the animals used in this study were healthy, male SpragueeDawley
rats obtained from Charles River Inc. (St. Constant, QC, Canada). At approx-
imately 3 weeks of age, 18 rats (mean body weight 301 13 g) were ran-
domly assigned into either the experimental or the control group. Surgical
procedures were performed on the right hind limb only. Fifteen rats under-
went transection of the anterior cruciate ligament with partial medial menis-
cectomy (ACLX). The non-operated, or left hind limbs of the ACLX animals
(LEFT) were used as a control group throughout the experiment, while the
three remaining rats were randomly assigned to a sham-operated group
(SHAM), to control for the effects of the surgery. The Animal Use Subcom-
mittee of the University of Western Ontario approved all animal manipula-
tions. Animals were monitored on a daily basis and, before any
experiment, their body weights were measured. Between imaging experi-
ments, all animals were housed in standard cages and permitted free activity
with food and water ad libitum.
All animals were deeply anaesthetized with a mixture of ketamine
(100 mg/ml), xylazine (5 mg/ml) and saline. The dose was maintained at
0.1 ml per 100 g of body weight throughout all surgical and imaging experi-
ments. After administering anesthetic, the rodents were given 0.1 ml per
100 g of body weight of the antibiotic Trisbrissen 24% (Schering Canada
Inc., Pointe Claire, QC, Canada). An incision measuring approximately
1 cm was made medial to the patella, allowing displacement of the patella
with the hind limb extended. The knee was subsequently ﬂexed and, with
a bent 27-gage needle, the medial meniscus was hooked and pulled gently
away from the tibial plateau. The synovial and tibial attachments of the me-
niscus were visualized and severed using a pair of dura scissors. Once the
medial meniscus was removed, and the anterior cruciate ligament (ACL) was
visualized, the same bent needle was used to hook the ligament and sever it.
Rigorous precautions were employed to avoid damage to articular surfaces,
which were kept moist throughout the procedure with sterile saline. Once the
procedure was complete, the incision was sutured in two layers. In SHAM,
the procedure was similar to the ACLX surgery. However, upon hooking
and gently pulling the medial meniscus away from the tibial plateau, the
incision was sutured in two layers. All ACLX and SHAM animals were
observed and neither appeared to favor the operated leg upon recovery
from anesthesia, nor at any time point afterward.
The hind limbs of all animals were imaged with micro-CT on the day prior
to surgical intervention and every 4 weeks post-surgery for up to 20 weeks
(six time points). In the ALCX group, three animals were euthanized
(n¼ 3) at each time point with an overdose of anesthetic following micro-
CT imaging, for use in another study.MICRO-CT PROTOCOLIn vivo micro-CT imaging was performed using a bench-top micro-CT
scanner (Locus, GEHC, London, ON, Canada) scanner. The imaging proto-
col was optimized over multiple pilot scans, using an excised rat knee stored
in formalin in a 50 ml tube, before any live animal scans were performed. The
X-ray tube has a tungsten target, with a nominal spot size of 50 mm, and
1.8 mm Al-equivalent ﬁltration. The protocol was designed so that X-ray pro-
jection views were acquired in 1 increments over 210. These projection im-
ages were the summation of ﬁve X-ray projections (each projection, acquired
over 400 ms at 80 kVp and 0.45 mA) that were averaged at each angular in-
crement to create one image. All acquisition images were subsequently cor-
rected with bright (i.e., X-ray image with nothing in the ﬁeld of view [FOV])
and dark (i.e., image acquired without X-rays) ﬁeld images. Finally, the
data were then reconstructed using a modiﬁed Feldkamp cone-beam recon-
struction algorithm37, resulting in a full 3D micro-CT volume with isotropic
voxel spacing of 46 46 46 mm. The micro-CT volume was calibrated in
the conventional linear scale of CT numbers, otherwise known as Hounsﬁeld
units (HU), wherein the values for water and air are 0 and 1000, respec-
tively. The entire time needed to acquire this micro-CT volume was approx-
imately 17 min.
Prior to scanning, the rodents were anaesthetized with the same
ketamineexylazine mixture described above. The animal was placed in the
supine position and a tissue calibration phantom was attached to the oper-
ated leg, which was splinted to prevent any motion during the scan. The
phantom was made of a 1 mm diameter cylinder of an epoxy-based material
that is known to mimic the radiographic properties of cortical bone (SB3,
Gamex RMI, Middleton, USA)38 [Fig. 1(b)]. The animal was subsequently
placed on a carbon ﬁber bed [Fig. 1(a)] that transported the animal into the
bore of the scanner. The 65 mm FOV provided by the micro-CT system
allows the simultaneous imaging of both hind limbs in one acquisition
[Fig. 1(b)]. Both operated (ACLX) and contralateral (LEFT) limbs were
Fig. 1. In vivo micro-CT imaging of both rodent hind limbs within the FOV provided by the GEHC Locus scanner. (a) Photograph of anaes-
thetized rodent supine on CT scanner bed. (b) Volume rendering of the CT image produced from our imaging protocol, visualized by GEHC
microview.
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systemic effects after the surgery39,40.
The image quality was quantitatively measured by determining the SNR
within the 3D micro-CT volume. This was achieved by placing a square re-
gion of interest (ROI) into two selected areas: a region identiﬁed as cortical
bone and an area of background material.
The SNR was deﬁned as:
SNR ¼ HUbone=sbackground
where HUbone is the mean CT number in the cortical bone calibrator, and
sbackground is the standard deviation (SD) within the image background.
Radiation dose
The entrance exposure rate was measured using a 15 cm3 ion chamber
(Model 96035, Keithley, Cleveland, USA) and electrometer (model 617, Keith-
ley, Cleveland, USA). It was found to be 190 mR/mAs at the isocentre, and
was used to estimate a total entrance X-ray dose of 0.36 Gy per micro-CT
volume acquisition. Dare et al.41 reported that single X-ray dose of up to
0.40 Gy did not affect cell growth and proliferation of osteoblast-like cells
in vitro. A single X-ray dose of 5 Gy can affect osteoblasts in the tibial
epiphysis42, however, our protocol exposed the ACLX and SHAM rodents
to a maximum total exposure of only 1.8 Gy over a period of 20 weeks.
Allowing adequate time for the rodents to recover from repeated irradiation
reduces the chance of radiation-induced damage to the joint. For lower
body irradiation, the recovery rate is approximately 33% of the lethal dose e
approximately 5e7 Gy whole body exposure for rats43,44 e per day45. There-
fore, allowing 4 weeks between micro-CT scans provides an adequate period
for the animal to recover from any possible effects of radiation.HISTOLOGICAL ANALYSISAt 5 months, the ACLX (n¼ 3), LEFT (n¼ 3), and SHAM rats (n¼ 3) were
euthanized by means of intracardial perfusion with 4% paraformaldehyde.
Both hind limbs were disarticulated and decalciﬁed in 15% EDTA/glycerol
(pH¼ 7.3) for up to 5 weeks. The knee joints were subsequently embedded
in parafﬁn wax and the medial joint compartment was serially sectioned in
the sagittal plane. Three sections e each 6 mm thick and 30 mm apart e
located between 270 and 330 mm from the medial joint margin, were stained
with Safranin-O/Fast Green46.
The Osteoarthritis Research Society International (OARSI) scoring
method46 was used to grade and stage OA degradation in SHAM, LEFT,
and ACLX medial knee joint compartments at 5 months in order to quantita-
tively assess subchondral bone degradation in addition to cartilage. The
grade and stage of both joint surfaces was determined, for three slides within
each knee joint, by a blinded observer. The OA score was calculated by mul-
tiplication of the grade and stage values for each slide. A minimum score of
0 represents no OA degradation and a maximum score of 24 represents the
highest degree of OA degradation in more than 50% of the section. Severe
characteristics of OA degradation assessed included cartilage denudation,
subchondral plate fracture, and evidence of bone repair. The score for
each medial compartment joint surface was assigned by determining the
average score of all slides assessed from that sample. The score fromboth surfaces of each joint was then averaged to achieve an OA score rep-
resenting OA degradation of the whole joint.IN VIVO BONE ANALYSISThe reconstructed micro-CT volumes were analyzed with 3D viewing soft-
ware (Microview 2.0.1; GE Biosciences, London, ON, Canada) as a multi-
planar reformatted image (MPR), allowing simultaneous examination of all
three planes (axial, coronal, and sagittal). All images were qualitatively
viewed in the sagittal and coronal planes for signs of joint degradation,
and development of OA, such as the presence of subchondral sclerosis,
osteophytes, soft tissue calciﬁcations, and bone cysts or edema.
vBMD
To ensure the accuracy and reproducibility of measuring parameters such
as vBMD, a consistent and reliable spatial sampling method was developed
initially for the use in human CT studies. This method was later adapted for
use with an ex vivo micro-CT-rabbit ACLX model by Batiste et al.14,15. The
knee joint was divided into four compartments (medial femur (MFC), lateral
femur (LFC), medial tibia (MTP), and lateral tibia (LTP)), each containing
anterior, central, and posterior cylindrical ROIs, providing a total of 12 sam-
pling locations (equivalent to ‘‘virtual biopsy’’ sites) per knee joint, as shown
in Fig. 2. The weight-bearing regions of both the femur and tibia were used to
ﬁnd the most anterior and posterior margins, thus creating a primary axis,
Y. Then, the most medial and lateral margins of the compartment were iden-
tiﬁed to create the secondary axis, X. Using these axes, a 2 4 grid was
created where the primary axis is divided into quarters (Y/4) and the second-
ary axis in half (X/2). The central ROI coordinates were deﬁned as the inter-
section between Y/2 and X/2; the coordinates for the anterior and posterior
ROIs require adjusting for anatomical variation. To accommodate for the nat-
ural curvature of the bones, the medial and lateral borders of the anterior and
posterior ROIs were determined by the boneetissue interface along the lines
Y/4 and Y3/4, respectively. Careful attention ensured that the anterior margin
in the femur did neither include the patellofemoral region, nor did the anterior
margin in the tibia include the tibial tuberosity; thereby maintaining the use of
weight-bearing regions of the joint exclusively when calculating the quantita-
tive bone parameters. The minimum distance between the subchondral plate
and the epiphyseal plate (as viewed in the coronal plane) determined the
Z position, or depth of the ROI; this distance varied between the femur
and tibia. Finally, cylindrical ROIs with a diameter of 0.75 mm were placed
in the six femoral and in the six tibial subchondral regions, with depths of
1.5 and 0.85 mm, respectively. These ROIs taken from speciﬁc, weight-
bearing compartments were composed of the subchondral bone plate and
the underlying epiphyseal trabecular bone.STATISTICAL ANALYSISThe vBMD was tabulated for all 12 anatomical locations within each
animal. The anterior, central, and posterior regions within each compartment
were averaged to create four compartment means: MFC, LFC, MTP, and
LTP14. Compartmental vBMD within each group (ACLX, SHAM, and LEFT)
was examined using a one-way repeated-measures analysis of variance
Fig. 2. Axial plane micro-CT slices displaying the anatomical ROIs as placed in the medial femoral condyle (a) and medial tibial plateau (b).
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any signiﬁcant relationships between time points. Paired t tests were imple-
mented to assess the change to compartmental vBMD during the experiment
between the ACLX and SHAM groups, and between the ACLX and LEFT
groups in each compartment at every time point. Differences were consid-
ered signiﬁcant for P< 0.05. All statistical analyses were performed using
Prism v4.0a, GraphPad Software Inc. (San Diego, CA, USA).ResultsIMAGE QUALITYThe in vivo micro-CT protocol gave an SNR of 19, at an
entrance dose of 0.36 Gy. This in vivo micro-CT protocol
provided sufﬁcient spatial resolution for qualitative visuali-
zation of the structure and morphology in subchondral
bone. Comparable assessments of signs of joint degrada-
tion and demineralization, such as changes to trabecular
morphology, could be achieved with the use of an ex vivo
protocol with a higher entrance dose.Table
Descriptive statistics for compartmental vBMD (meanSD), body weig
SHAM, LEFT, and ACLX rodents throughout the course of the experim
hind limbs of the same rat) are identical. The OARSI score represen
vBMD (mg cm3)
Compartment Pre-surgical 1 month 2 months
SHAM n¼ 3
(292 9 g)
n¼ 3
(383 8 g)
n¼ 3
(424 13 g)
LFC 502 41 700 52 722 84
MFC 463 56 657 24 671 77
LTP 489 50 641 78 647 91
MTP 507 64 704 58 716 90
LEFT n¼ 15
(310 9 g)
n¼ 15
(409 9 g)
n¼ 12
(463 13 g)
LFC 533 57 696 101 654 66
MFC 543 51 685 88 672 68
LTP 530 54 646 90 649 52
MTP 574 54 723 93 721 91
ACLX n¼ 15 n¼ 15 n¼ 12
LFC 528 68 621 52 705 53
MFC 511 74 584 49 679 35
LTP 513 66 556 67 636 51
MTP 546 69 624 69 706 54QUANTITATIVE CHANGES TO OA JOINTSValues reported within the threeROIs (anterior, central, and
posterior) in each compartment (LFC, MFC, LTP, and MTP)
were averaged, producing a single compartment mean14.
For all rodents in each group, the femoral ROIs were
composedofapproximately5670voxels,withacorresponding
volume of 0.60 ml. The number of voxels and corresponding
volume in the tibial ROIs were 3270 and 0.35 ml, respectively.
Repeated-measures ANOVA revealed that the main effect
of time post-surgery was signiﬁcant for each compartmental
vBMD for all groups (P< 0.001). Summaries of the descriptive
statistics for all groups are provided in Table I.
Measurement of vBMD between surgical groups
The difference in vBMD from pre-surgical determination
was calculated and plotted in Fig. 3. The vBMD data con-
sisting of the rat knees used throughout the entire experi-
ment (n¼ 3 for each group) is plotted in Fig. 4. PairedI
ht (meanSD) in grams, and OARSI score (meanSD) for the
ent. Note the body weights for the ACLX and LEFT groups (both
ts the average score for both femoral and tibial joint surfaces
OARSI score
3 months 4 months 5 months 5 months
n¼ 3
(490 3 g)
n¼ 3
(549 7 g)
n¼ 3
(596 6 g)
n¼ 3
695 22 719 63 744 46 0.3 0.3
659 36 697 86 720 58
638 54 643 100 694 81
700 23 710 55 740 9
n¼ 9
(519 18 g)
n¼ 6
(579 9 g)
n¼ 3
(622 16 g)
n¼ 3
685 46 689 74 796 56 1.6 1.3
664 28 674 37 751 77
659 44 626 51 708 55
718 48 731 11 818 82
n¼ 9 n¼ 6 n¼ 3 n¼ 3
688 50 647 47 684 49 19.8 1.7
650 53 598 42 669 69
618 70 582 59 638 26
660 84 626 68 683 43
Fig. 3. Longitudinal changes to vBMD (mean S.E.M.) within the four anatomical compartments for all rodents in all surgical groups. *P< 0.01
vs ACLX, **P< 0.001 vs ACLX, #P< 0.05 vs ACLX, gP< 0.01 1 month vs 2 months ACLX, ggP< 0.001 1 month vs 2 month ACLX, xP> 0.05
vs pre-surgical vBMD.
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surgical LEFT group were unexpectedly greater than vBMD
values for pre-surgical SHAM knees (P< 0.05); no other
signiﬁcant differences between the LEFT and SHAM
groups were found at any other time point. The vBMD in
SHAM knees was also lower than the vBMD in ACLX
(i.e., right) knees prior to surgery, although it should be
noted that, pre-surgical values obtained in the SHAM group
were on average within 45 mg cm3 (8%) of both the ACLX
and LEFT limbs. All pre-surgical rat knees scanned ex-
hibited a wider epiphyseal growth plate than observed at
all time points post-surgery. Immediately 1 month after
surgery, however, the SHAM and LEFT groups exhibited
signiﬁcantly higher vBMD than the ACLX limb (P< 0.01).
No signiﬁcant differences in vBMD were found again until
4 months after surgery, at which point the SHAM and
LEFT limbs were signiﬁcantly higher than the ACLX group
(P< 0.01 and P< 0.05, respectively). The ACLX animals
exhibited an overall decrease of 6.3% (41 mg cm3) in
vBMD at 4 months. There was a 9% (55 mg cm3) overall
increase in vBMD, from 4 to 5 months by the ACLX group,
though still signiﬁcantly lower than the vBMD in both SHAM
and LEFT groups.
Longitudinal changes to vBMD
Within both femoral compartments, the LFC and MFC,
Tukey post hoc tests revealed that the vBMD within the
ACLX rats was signiﬁcantly higher at all time pointspost-ACLX than their pre-surgical (pre-ACLX) measure-
ment (P< 0.001). The only other signiﬁcant difference ob-
served along time points post-ACLX was between 1 and 2
months; where there was a vBMD increase of 13.7%
(85 mg cm3) in the LFC (P< 0.01), and 16.3%
(95 mg cm3) in the MFC vBMD (P< 0.001). In the femoral
compartments for both the LEFT and SHAM knees, the only
signiﬁcant differences in vBMD were found between all
post-intervention time points vs values determined pre-
intervention (P< 0.05 and P< 0.01, for the LEFT and
SHAM femoral compartments, respectively).
The LTP in the ACLX group was the only compartment in
which the 1 month post-ACLX vBMD was not signiﬁcantly
higher than pre-ACLX (P> 0.05). The vBMD of both the
LTP and MTP of the ACLX decreased from 3 to 4 months
post-ACLX by 5.9% (36mg cm3) and 5.2% (34 mg cm3),
respectively. Four months post-ACLX, the vBMD in the tibia
was not signiﬁcantly higher than the pre-ACLX values
(P> 0.05) in each compartment. Subsequently, at 5 months
post-ACLX, the vBMD in the LTP and MTP increased signif-
icantly higher again than pre-ACLX (P< 0.05 and P< 0.01,
respectively). However, the only signiﬁcant difference
observed between post-ACLX vBMD in the tibia occurred
between 1 and 2 months (P< 0.05). The pattern for com-
partmental vBMD within the femur of SHAM animals was
duplicated in their LTP and MTP compartments; demon-
strating a signiﬁcantly higher vBMD (P< 0.05 and
P< 0.01, respectively) in all post-SHAM time points vs the
pre-SHAM. The LEFT LTP compartmental vBMD exhibited
Fig. 4. Longitudinal in vivo vBMD measurements (mean S.E.M.) within the (a) LFC, (b) MFC, (c) LTP, and (d) MTP compartments for the
rodents imaged at each time point throughout the entire study (ACLX, LEFT, and SHAM groups, n¼ 3).
463Osteoarthritis and Cartilage Vol. 16, No. 4a similar trend to the LTP of the ACLX group, although the
decrease in vBMD at 4 months was still signiﬁcantly higher
than pre-LEFT (P< 0.05). Upon reaching 5 months, the
vBMD in both tibial compartments of the LEFT group in-
creased by 13.1% (82 mg cm3) in the LTP, and 11.8%
(86 mg cm3) in the MTP, although not signiﬁcantly higher
than any of the post-LEFT values.
Cartilage degradation
Examination of the in vivo sagittal micro-CT images of the
medial joints at 5 months revealed superﬁcial damage to
the subchondral bone, as evidenced by sclerosis and thick-
ening of the subchondral plate of both the femur and tibia of
the ACLX joints [Fig. 5(a)] compared to LEFT [Fig. 5(b)] and
SHAM (not shown) joints. These joints were ﬁxed, decalci-
ﬁed and subjected to histological analysis with Safranin-O
and Fast Green staining. Almost all of the articular cartilage
was eroded from the femur and tibia of ACLX animals
[Fig. 5(c)], whereas a fully intact joint surface with evenly
distributed chondrocytes was observed in the hind limbs
of SHAM and LEFT animals [Fig. 5(d)]. Upon closer inspec-
tion of the ACLX tissue, we found areas where the subchon-
dral bone was invaded with cartilaginous and other ﬁbrous
tissue [Fig. 5(c)] suggesting that remodeling processes
were being carried out within the OA joint. The mean
OARSI score of the 5-month ACLX hind limbs (19.8 1.7)was signiﬁcantly higher than both the SHAM and LEFT
groups (P< 0.01, Table I). While no signiﬁcant difference
was found between the control groups (0.3 0.3 and
1.6 1.3, respectively).QUALITATIVE CHANGES TO OA JOINTSBone cyst formation
Qualitative investigation of the medial knee joint from the
coronal view of the micro-CT images revealed radiolucent
areas in both the MFC and MTP, as shown in Fig. 6. Within
the MTP, the small focal areas of bone resorption appeared
in the weight-bearing regions of 92% of the knees (n¼ 11)
at 2 months post-ACLX. These areas are consistent with
the formation of subchondral bone cysts. There was a no-
ticeable breach of the subchondral plate associated with
the formation of cysts [Fig. 6(c)]. The subchondral bone
cysts appeared to increase, in area as well as number, in
all post-ACLX rats throughout the ﬁnal time points, how-
ever, the breach to the subchondral plate appeared to be
covered with mature osteoid after 3 months. The subchon-
dral cysts in the posterior aspect of the MFC were more var-
iable in size and rate of appearance. Active sites of
resorption appeared further away from the articular surface
at 3 months post-ACLX in only 56% of the animals (ﬁve out
of nine). By 4 months, 83% (ﬁve out of six) of ACLX knees
Fig. 5. Comparison of the tissue changes to the medial joint surfaces. Sagittal in vivo micro-CT image of the ACLX (a) and LEFT (b) rodent
hind limbs 5 months post-surgery. Note the subchondral plate thickening and loss of mature trabecular bone pattern (a) vs the LEFT limb (b).
Joints were ﬁxed, decalciﬁed, and processed for histological staining with Safranin-O and Fast Green. The histological sections were manually
registered to the boxed areas of the micro-CT images. Note the delamination of cartilage within the ACLX joint (c), a small remaining tissue
fragment (arrow) containing a cluster of chondrocytes. The subchondral bone was invaded at several points (c e vertical arrowhead); while the
underlying bony trabeculae were surrounded by ﬁbrous tissue (c e horizontal arrowheads). The cartilage and bone tissue of LEFT limb (d)
appeared normal with a consistent, uninterrupted joint surface (arrowheads) and evenly distributed chondrocytes. Scale bar in (c) and
(d)¼ 0.5 mm.
464 D. D. McErlain et al.: In vivo micro-CT in a rodent model of OAshowed a loss of mature trabecular bone in the MFC, and at
5 months, all ACLX rodents showed enlarged cyst formation
throughout the central and posterior MFC compartments.
No cysts or articular surface abnormalities were observed
within the LFC or LTP of ACLX animals. No cysts were
observed in any compartment of either the SHAM-operated
or the LEFT (contralateral) limb at any time points.
Histological analysis of these subchondral cysts (Fig. 7)
revealed sites of bone resorption, and a predominance of ﬁ-
brous tissue deposition surrounding regions consistent with
marrow and non-marrow components. The tissue that re-
placed cancellous bone displayed increased cellularity,
coupled to a more disorganized ﬁber arrangement anddensity; as evidenced by paler staining than neighboring
bone, resembling hyperplastic connective tissue [Fig. 6(d)].
Patellar tendon calcification
Examination of the ACLX knee joints in the sagittal plane
directly between the medial and lateral compartments
revealed ossiﬁcation of the patellar tendon (Fig. 8). This
developed as small calciﬁcations just inferior to the mid-
section of all patellae (n¼ 12) 2 months post-ACLX. By
the end stage of the experiment, the bone formation demon-
strated a cancellous structure in the middle, surrounded by
a more dense, cortical bone network indicating heterotopic
Fig. 6. Trabecular bone erosion with cyst formation in ACLX knee over time. Coronal in vivomicro-CT view at pre-surgical (a), 1 (b), 2 (c), 3 (d),
4 (e), and 5 (f) months post-surgery. Note the breach and eventual covering of the subchondral plate with immature bone (arrowheads), and
the increasing area of cysts over time (arrows) within the same animal. These results are representative of ﬁndings in all ACLX animals in this
study.
465Osteoarthritis and Cartilage Vol. 16, No. 4ossiﬁcation, a form of the more commonly known myositis
ossiﬁcans47. This patellar tendon calciﬁcation appeared in
only one (33%) of the SHAM group, after 3 months, and
was not found in any of the LEFT hind limbs.Fig. 7. Histological analysis of subchondral bone cysts in the medial fem
micro-CT image (a), there are large cavities under the articular surface
were stained with Safranin-O and Fast Green (b). Note the delaminated a
chondral bone, as seen in Fig. 4(d), has been replaced with hyperplastic, ﬁ
(arrow). Scale baThe qualitative analysis of the joints revealed sclerosis of
the subchondral plate in all ACLX rats, with some evidence
of marginal osteophytes in the LFC. However, the formation
of these osteophytes did not appear until the later stages oforal condyle at 5 months post-ACLX. As predicted by the sagittal
(rectangle). Tissue sections of 5 months post-ACLX knee joints
rticular cartilage (vertical arrowheads). The typically expansive sub-
brous tissue (horizontal arrowheads), with some marrow component
r¼ 1 mm.
Fig. 8. Sagittal plane in vivo micro-CT images from the mid-line of the joint revealing changes to patellar tendon in the ACLX (aec) and SHAM
(def) rodent hind limbs, at 1 month (a,d), 2 months (b,e), and at 5 months (c,f) post-surgery. Note: no calciﬁcation in (a), mild calciﬁcation in (b)
(arrow), with eventual heterotopic ossiﬁcation at 5 months (arrow, c). Although not seen here, some minor calciﬁcation of the tendon was found
in one SHAM hind limb.
466 D. D. McErlain et al.: In vivo micro-CT in a rodent model of OAdevelopment in less than one third of the animals. Neither
the SHAM nor the LEFT group exhibited any major changes
in subchondral plate thickness, surface roughness, or os-
teophyte formation.
Discussion
The goal of this study was to characterize and validate
a quantitative, non-invasive, and longitudinal rodent model
of surgically induced OA, using in vivo micro-CT to monitor
the changes to subchondral bone. This is the ﬁrst in vivo
study to examine vBMD over an extended period of time
post-ACLX (5 months) in the same animal revealing a signif-
icantly lower vBMD in ACLX animals vs non-destabilized
controls. The lower vBMD in ACLX animals was found at
both the early and late stages of our experiment. The strength
of this in vivomicro-CT protocol is the ability to conduct a lon-
gitudinal study with effective measures of qualitative and
quantitative changes to subchondral and trabecular bone
within the same rodent without any adverse effects.IMAGE QUALITYThe SNR and nominal spatial resolution (0.045 mm) pro-
vided by the in vivo scanner was adequate for determination
of regional vBMD in anobject as small as the rat hind limb.Wechose to characterize vBMD, rather than stereological or ar-
chitectural parameters (such as trabecular thickness, bone-
volume fraction, or structural model index)48,49, due to the
fact that vBMD is less dependent on spatial resolution and
therefore more precise in detecting and monitoring changes
to subchondral, and underlying trabecular bone in a rodent
model of ACLX14. Stereological parameters require grey-
scale segmentation of an image, based on a selected thresh-
old, making them sensitive to partial-volume effects that are
inherent in CT of small structures50. A recent study using por-
cine bones found that small changes in threshold values can
lead tomuchgreater differences in bone-volume fraction (BV/
TV)51. In humans, it has been proposed that the spatial reso-
lution must be at least 0.175 mm in order to evaluate trabec-
ular bone morphology52. Morphological parameters have
been used to characterize ex vivo rat bones, though these
analyses were performed with much higher nominal spatial
resolution (as small as 0.006 mm)53. Although such high-
spatial resolution micro-CT scans are possible, the X-ray
dose to the animal and scan time would increase signiﬁ-
cantly30, precluding routine in vivo application.LONGITUDINAL vBMDThe values for vBMD increased signiﬁcantly post-inter-
vention in all three groups. This indicates that the animals
467Osteoarthritis and Cartilage Vol. 16, No. 4used were not skeletally mature prior to the start of the
study, as suggested by the wider epiphyseal growth plate
seen pre-surgically vs other time points (Fig. 6). All rats
were weighed before proceeding with surgery, however,
DeMoss and Wright found that mature skeletal develop-
ment was only partially related to body mass54. Therefore,
using body mass to determine skeletal maturity, although
often used55, is not a reliable estimate. The screening of
epiphyseal growth plates with micro-CT scanning could be
used in future investigations to ascertain the skeletal matu-
rity of the animals before surgery, regardless of body
weight56.
Studies in humans indicate that BMD increases in OA
patients, compared to the normal population57,58. However,
data from 3D dual energy X-ray absorptiometry (DEXA)
analysis found a decrease in vBMD with early signs of
OA59. Buckland-Wright identiﬁed that even with subchon-
dral plate sclerosis seen in radiographs at advanced stages
of OA, there is a loss of mature bone matrix immediately be-
neath the subchondral plate60. The quality of bone in this
thickened subchondral plate was found to be less stiff, con-
taining lower amounts of bone mineral with altered matrix
properties compared to non-OA bone61. This non-linear re-
lationship between vBMD and OA was seen in the ACLX
hind limbs. The vBMD for the pre-SHAM group was signiﬁ-
cantly lower than the ACLX and LEFT groups. However, 1
month after surgery the vBMD in both the LEFT and
SHAM limbs increased signiﬁcantly relative to the ACLX
limb. OA models using dogs and rabbits consider the time
point 1 month after surgical destabilization to represent an
early stage of OA development14,62, in which the vBMD de-
creases. This early decrease is due to signiﬁcant bone re-
sorption, and has been observed in dogs63 and as early
as 2 weeks post-ACLX in rats64. Our results conﬁrm these
ﬁndings, as the mechanically destabilized limb had signiﬁ-
cantly lower vBMD, even after controlling for the effects of
surgery.
A strength of the present study is that we extended the
analysis in the same rats and could monitor changes to
vBMD within a given animal. The ACLX hind limb recovered
from the earlier loss of vBMD at 2 and 3 months, which in-
dicates a net increase in bone mass with changes to struc-
tural geometry65. As described by Burr, the advanced
stages of OA are characterized by remodeling of subchon-
dral bone, resulting in decreased density and stiffness.
A poor remodeling process, found in the OA rodents at 4
months, showed an approximate 12% loss in vBMD, indi-
cating an increase in bone turnover in the diseased joint66.
The vBMD values in the tibia speciﬁcally, did not differ
signiﬁcantly from the pre-surgical values at 4 months
post-ACLX [Fig. 3(c,d)]. The increased bone turnover ap-
peared to be a systemic response, as the LEFT or contra-
lateral hind limb showed a mild decrease in LTP vBMD
[Fig. 3(c)], although not signiﬁcant from other time points.
Even with a seemingly systemic increase in vBMD 5
months post-ACLX, the OA limb remained signiﬁcantly
lower than the SHAM animals. Studies with durations as
long as 54 months67 found an increased subchondral plate
thickness and bone formation, with BMD values signiﬁ-
cantly higher than those obtained in the early stage OA.
Similarly, our study demonstrated an increase in vBMD
from 4 to 5 months post-ACLX, within the same animal. Al-
though this increase in vBMD was not statistically signiﬁ-
cant, our study may have been limited by the smaller
sample size at 5 months ACLX (n¼ 3) than at 1 month
ACLX (n¼ 15). A retrospective statistical analysis using
a two-tailed, unpaired t test indicated that differences ofapproximately 80 mg cm3 between groups would be con-
sidered signiﬁcant (P< 0.05) with n¼ 8 animals and 80%
power. However, results amongst our sample size were
very consistent as evidenced by the small variability of
vBMD data (Table I), and statistically signiﬁcant differences
were detected between groups of equal sample size
(Fig. 3).QUALITATIVE CHANGES TO OA JOINTSThe beneﬁt of observing animals longitudinally e vs mul-
tiple specimens at each time point e is a reduction in inter-
specimen variability. While investigating the qualitative
changes to the ACLX joint, we were able to successfully
monitor the initiation and progression of subchondral bone
cysts, seen as early as 2 months post-ACLX. Studies using
an iodoacetate-induced rodent model report subchondral
cysts with subsequent loss of trabecular structure within 3
weeks of OA induction68. In human OA, subchondral cysts
are believed to arise in weight-bearing regions of joints
through two possible mechanisms: synovial intrusion or
bony contusion69,70. Synovial intrusion is depicted by carti-
lage degeneration, allowing synovial ﬂuid into subchondral
bone through gaps in the subchondral plate. These cysts
initially have open communication with the joint until becom-
ing occluded by ﬁbrous tissue71. The second mechanism,
bony contusion, is also initiated by cartilage degeneration
from abnormal stress; the difference occurs when micro-
fractures in the trabeculae, coupled with vascular insufﬁ-
ciency for repair, cause cyst formation. Unfortunately, we
cannot yet conﬁrm which mechanism best deﬁnes the
cyst formation in our model until a more detailed histomor-
phometric analysis is completed. Furthermore, cystic tissue
in OA is capable of recruiting and activating higher numbers
of osteoclasts in rats68,72 than non-OA tissue. This would
explain the longitudinal expansion of the lesions, seen es-
pecially in the MFC of the ACLX hind limb. It should be
noted that these animals did not undergo any surgical re-
construction of the knee to prevent further degeneration of
the joint over the 5 months post-surgery. In addition, the
joint changes found in the rat knee are more severe, and
the expansion of cystic tissue was beyond what is normally
be seen in human OA73, or other animal models. OA sever-
ity is normally monitored with radiographs in humans22,74,
which neither typically detect disease severity24,75 nor sub-
chondral cysts well76. Therefore, the use of 3D imaging mo-
dalities, such as CT, may improve the detection of painful
subchondral bone deformations.
The pathological ossiﬁcation of muscle tendons has been
reported in various joints in humans77,78, and in the knee
following traumatic injury79 or reconstructive surgery47,
causing serious pain and disability. Heterotopic ossiﬁcation
seen in the patellar tendon of all ACLX animals was origi-
nally thought to arise from a change in gait pattern caused
by the mechanical destabilization. After observing the same
ossiﬁcation in one of three of SHAM animals, we now pos-
tulate that it may originate from the retraction of the patella
during both surgeries. This retraction causes bleeding from
the tendon, which can clot and mineralize into a mature
bone structure. Tendon calciﬁcation is likely a wound-
healing response to surgery, as it was not observed in
any contralateral limbs.
This study is the ﬁrst to use in vivo micro-CT technology
to monitor and validate a long-term small animal model of
secondary OA. Transection of the ACL with medial meni-
sectomy in rodents leads to degenerative changes in
468 D. D. McErlain et al.: In vivo micro-CT in a rodent model of OAsubchondral and trabecular bone identical to those seen in
humans. The progressive changes to vBMD, subchondral,
and trabecular bone after ACLX were signiﬁcantly different
than control groups in early- and late-stage OA, even after
controlling for the effect of surgery. In vivo micro-CT was
able to measure signiﬁcant changes in vBMD, heterotopic
ossiﬁcation, and subchondral cyst formation within the
same animals over time. Simultaneously scanning both
hind limbs identiﬁed no signiﬁcant differences in vBMD for
the SHAM-operated and non-operated LEFT group at any
time after surgery. Our in vivo micro-CT technique has
been applied in an independent study of the effect of forced
mobilization on the rodent ACLX model of OA80. This study
provides novel insights into changes occurring in both car-
tilaginous and bony tissues during the progression of OA,
using repeated, non-destructive, analysis over time in the
same animal. Micro-CT can be applied in future pre-clinical
trials, to non-destructively determine the response to any
pharmacological interventions that may inﬂuence the bone
within articular joints in vivo.
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